C21-28 ALKANE
C21-28 ALKANE is a cosmetic ingredient classified as Skin Conditioning. Also known as CAS 64742-55-8. It is regulated in 1 market including Brazil.
Also Known As
- CAS Number
- 64742-55-8
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for C21-28 ALKANE in European Union, United Kingdom.
Americas1 regulation
- Chemical name
- Destilados (petróleo), parafínicos leves tratados com hidrogênio, se contiverem > 3 % (m/m) de extrato DMSO
- CAS
- 64742-55-8
Source: ANVISA RDC 529
East Asia & OceaniaNo restrictions
No specific restrictions for C21-28 ALKANE in South Korea, Japan, Taiwan, Australia.
ASEANNo restrictions
No specific restrictions for C21-28 ALKANE in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for C21-28 ALKANE in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for C21-28 ALKANE in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is C21-28 ALKANE banned in any country?
Yes, C21-28 ALKANE is banned in Brazil. Always check current regulations before formulating products for these markets.
What are the restrictions on C21-28 ALKANE in cosmetics?
C21-28 ALKANE is banned in Brazil and has no specific restrictions in other tracked markets.
Can I use C21-28 ALKANE in cosmetics?
C21-28 ALKANE is regulated in 1 market. It is banned in Brazil. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.
Screen C21-28 ALKANE with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.